CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Pegfilgrastim for Review
  • Thu, 16-Feb-2017
  • Posted by: BIOCON
No Comments

Biocon Foundation & Department of Medical, Health & Family Welfare, Govt. of Karnataka Collaborate to Set Up Smart eLAJ Clinics in Karnataka
  • Tue, 07-Feb-2017
  • Posted by: BIOCON
No Comments

Biocon Wins MYR 300 Million Contract for Insulin from MoH, Malaysia
  • Wed, 25-Jan-2017
  • Posted by: BIOCON
No Comments

Biocon Q3 FY17 Net Profit Up 65% at Rs 171 Crore Revenue Rises 32% at Rs 1092 Crore; EBITDA Increases 57% to Rs 324 Crore
  • Tue, 24-Jan-2017
  • Posted by: BIOCON
No Comments

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Trastuzumab
  • Wed, 11-Jan-2017
  • Posted by: BIOCON
No Comments

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data
  • Tue, 27-Dec-2016
  • Posted by: BIOCON
No Comments

Biocon Features in Asia IP Elite 2016 List
  • Fri, 09-Dec-2016
  • Posted by: BIOCON
No Comments

Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI
  • Tue, 29-Nov-2016
  • Posted by: BIOCON
No Comments

Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India
  • Fri, 11-Nov-2016
  • Posted by: BIOCON
No Comments

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab
  • Tue, 08-Nov-2016
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>